<DOC>
	<DOCNO>NCT00778089</DOCNO>
	<brief_summary>The purpose study assess clinical utility ArteFill® pre-treatment Skin Test predict prevent hypersensitivity reaction treatment ArteFill® implant</brief_summary>
	<brief_title>Open-Label Study Evaluate Immunogenicity Bovine Collagen ArteFill® Skin Testing</brief_title>
	<detailed_description>This single-center , open-label study approximately 485 healthy male female subject obtain 450 evaluable subject . In protocol , ArteFill® Skin Test study conduct evaluate test 's clinical utility determine incidence positive skin reaction ArteFill® . The result skin test study determine risk hypersensitivity reaction ArteFill® without skin test great publish historical risk hypersensitivity reaction Zyderm Zyplast treatment patient demonstrate negative response single Zyderm skin test . Based prior clinical experience ArteFill® implant commercial use outside United States , anticipate reaction observe . As , may suggest practical use ArteFill® Skin Test screening patient , therefore , test may eliminate requirement prior treatment ArteFill® product clinical practice outside United States .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Polymethyl Methacrylate</mesh_term>
	<criteria>Subjects 18 year age old , male female . Subjects healthy normal skin volar surface forearm . Subjects willing able comply requirement study . Subjects willing able comply followup requirement . Subjects willing able give write verbal informed consent . Subjects pregnant , nurse intend become pregnant . Subjects form collagen soft tissue treatment within last 12 month . Subjects currently treat systemic immunosuppressive therapy include limited chemotherapy agent corticosteroid ( include inhale insufflate ) within past 3 month . Subjects currently treat topical OTC drug prescription therapy arm ( elbow ) within past 3 month . Subjects history indicative abnormal immune function ( e.g . auto immune disease , HIV , cancer , etc ) . Subjects know lidocaine hypersensitivity . Subjects know sensitivity bovine collagen . Subjects history dietary beef allergy , undergo desensitization beef product plan undergo desensitization within study evaluation period . Subjects severe allergy manifest history anaphylaxis . Subject currently enrol investigational drug device study . Subject receive investigational drug investigational device within 30 day prior enter study . Subject skin pathology condition could interfere evaluation treatment area .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>skin test</keyword>
	<keyword>ArteFill</keyword>
	<keyword>Skin test prior administration ArteFill® implant</keyword>
</DOC>